浏览全部资源
扫码关注微信
海南省中医院,海口 570203
*刘宜峰,博士,副主任中医师,从事中医内科和全科医学临床、教学及科研研究工作,E-mail:gobebs@163.xom
纸质出版日期:2020-05-05,
网络出版日期:2019-10-21,
收稿日期:2019-09-03,
扫 描 看 全 文
刘宜峰, 曹磊, 杨华, 等. 薏苡仁汤加减内外合治对急性痛风性关节炎湿热痹阻证炎症因子的影响[J]. 中国实验方剂学杂志, 2020,26(9):75-80.
Yi-feng LIU, Lei CAO, Hua YANG, et al. Effect of Addition and Subtraction Therapy of Yiyiren Tang with External Application Therapy on Inflammatory Factors of Patients with Acute Gouty Arthritis and Damp-heat Obstruction Syndrome[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2020,26(9):75-80.
刘宜峰, 曹磊, 杨华, 等. 薏苡仁汤加减内外合治对急性痛风性关节炎湿热痹阻证炎症因子的影响[J]. 中国实验方剂学杂志, 2020,26(9):75-80. DOI: 10.13422/j.cnki.syfjx.20200132.
Yi-feng LIU, Lei CAO, Hua YANG, et al. Effect of Addition and Subtraction Therapy of Yiyiren Tang with External Application Therapy on Inflammatory Factors of Patients with Acute Gouty Arthritis and Damp-heat Obstruction Syndrome[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2020,26(9):75-80. DOI: 10.13422/j.cnki.syfjx.20200132.
目的:
2
观察薏苡仁汤加减内服和外敷治疗急性痛风性关节炎(AGA)湿热痹阻证的临床疗效及对炎症因子的影响。
方法:
2
将153例AGA患者随机按数字表法分为对照组77例和观察组76例。对照组采用美洛昔康片,1片/次,1次/d,饭后服用;双氯芬酸钠凝胶,适量外涂患处,适当按摩,3次/d。观察组美洛昔康片使用同对照组,并给予薏苡仁汤加减内服、外敷。两组疗程均为治疗7 d。患者每日记录疼痛视觉模拟评分(VAS),记录疼痛缓解时间和疼痛消失时间;进行治疗前后湿热痹阻证评分;检测治疗前后尿酸(UA),C-反应蛋白(CRP),红细胞沉降率(ESR),白细胞介素-1
β
(IL-1
β
),IL-6,IL-8,肿瘤坏死因子-
α
(TNF-
α
),血清环氧合酶-2(COX-2),前列腺素E
2
(PGE
2
),血栓素B
2
(TXB
2
)和6-酮-前列腺素F
1
α
(6-keto-PGF
1
α
)水平;进行安全性评价。
结果:
2
观察组临床疗效优于对照组(
Z
=2.205,
P
<
0.05);观察组疼痛缓解时间和疼痛消失时间均短于对照组(
P
<
0.01);观察组在治疗后1,3,5,7 d的VAS评分均低于对照组(
P
<
0.01);治疗后观察组关节疼痛、关节压痛、关节肿胀、活动障碍等主证评分、次证评分和湿热痹阻证总分均低于对照组(
P
<
0.01);治疗后观察组ESR,CRP,UA,IL-1
β
,IL-6,IL-8,TNF-
α
,COX-2,PGE
2
和TXB
2
水平均低于对照组(
P
<
0.01),6-keto-PGF
1
α
水平高于对照组(
P
<
0.01)。
结论:
2
在美洛昔康片治疗的基础上,采用薏苡仁汤加减内服、外敷治疗AGA湿热痹阻证患者可快速缓解和消除疼痛,减轻临床主要症状,抑制炎症反应,有着较好的临床疗效,且使用安全。
Objective:
2
To observe the clinical effect of addition and subtraction therapy of Yiyiren Tang with external application therapy in the patients with acute gouty arthritis (AGA) and damp-heat obstruction syndrome
and to investigate its effect on inflammatory factors.
Method:
2
One hundred and fifty-three patients were randomly divided into control group (77 cases) and observation group (76 cases) by random number table. Patients in control group got meloxicam tablets after the meal
1 tablet/day
1 time/day
diclofenac sodium gel
3 times/days. On the basis of meloxicam tablets
patients in observation group additionally received addition and subtraction therapy of Yiyiren Tang by oral and topical applications. The course of treatment was 7 days in both groups. Scores of visual analogue score of pain (VAS) were graded everyday
and the relief time and disappearance time of pain were recorded. Before and after treatment
scores of damp-heat obstruction syndrome were recorded. Levels of uric acid (UA)
C-reactive protein (CRP)
erythrocyte sedimentation rate (ESR)
interleukin-1 beta (IL-1
β
)
interleukin-6 (IL-6)
interleukin-8 (IL-8)
tumor necrosis factor-alpha (TNF-
α
)
serum cyclooxygenase-2 (COX-2)
prostaglandin E
2
(PGE
2
)
thromboxane B
2
(TXB
2
) and 6-keto-prostatic factor F1alpha (6-keto-PGF
1
α
) were all detected
and the safety was evaluated.
Result:
2
The clinical efficacy in observation group was better than that in control group (
Z
=2.205
P
<
0.05). The relief time and disappearance time of pain were shorter than those in control group (
P
<
0.01). At the 1
st
3
rd
5
th
and 7
th
day after treatment
scores of VAS were lower than those in control group (
P
<
0.01). After treatment
the scores of main symptoms such as joint pain
tenderness
swelling and dyskinesia
scores of the secondary symptoms and the total scores of damp-heat obstruction syndrome were all lower than those in control group (
P
<
0.01). After treatment
levels of ESR
CRP
UA
IL-1
β
IL-6
IL-8
TNF-
α
COX-2
PGE
2
and TXB
2
were all lower than those in control group (
P
<
0.01).
Conclusion:
2
Based on the treatment of meloxicam
addition and subtraction therapy of Yiyiren Tang by oral and topical administration methods can quickly relieve and eliminate pain
alleviate the main clinical symptoms and inhibit inflammation in patients with damp-heat obstruction syndrome
showing good clinical efficacy and safety.
急性痛风性关节炎湿热痹阻证薏苡仁汤内外合治炎症因子
acute gouty arthritisdamp-heat obstruction syndromeYiyiren Tangoral and topical administrationinflammatory factors
中华医学会风湿病学分会.2016中国痛风诊疗指南[J].中华内科杂志,2016,55(11):892-899.
舒建龙,李凤珍,覃裕旺.痛风病理及临床中西医治疗的研究进展[J].中国实验方剂学杂志,2019,26(18):1-10.
谷慧敏,孟庆良,左瑞庭,等.蚕矢汤加减治疗痛风性关节炎湿热蕴结证临床观察[J].中国实验方剂学杂志,2017,23(24):180-184.
尹磊,林丽雅,李学峰.急性痛风性关节炎中西医治疗研究进展[J].河北医药,2017,39(5):751-756,759.
高岚,张仲一,张莉,等.薏苡仁汤镇痛消炎作用的实验研究[J].天津中医学院学报,2005,24(1):17-19.
卿璞.薏苡仁汤加减治疗痛风性关节炎的临床研究[J].中国医药指南,2014,12(28):271-272.
国家中医药管理局.中医病证诊断疗效标准[M].北京:中国医药科技出版社,2012:63-64.
于一云,薛愉,朱小霞,等.急性痛风性关节炎的药物治疗及选择[J].上海医药,2015,36(11):14-18.
李君霞,王茂杰,黄闰月,等.痛风中医证型的研究进展[J].中华中医药学刊,2018,36(12):2956-2958.
于娟,王晓梅.薏苡仁和茯苓提取物对黄嘌呤氧化酶的抑制作用[J].中国药物与临床,2014,14(1):30-32.
金晓敏,张晓熙,郭璐,等.基于NLRP3炎性体轴探讨土茯苓总黄酮对痛风性关节炎的作用和机制[J].中国实验方剂学杂志,2018,24(4):90-95.
于舒雁,魏荣锐,苗明三.不同品种威灵仙水煎液外用对大鼠痔疮、佐剂性关节炎模型的影响[J].中国现代应用药学,2014,31(4):391-397.
廉莲,贾天柱.黄柏及其炮制品的抗痛风作用研究[J].安徽农业科学,2011,39(15):8911-8912.
张柯媛,熊灏,曹斌,等.海风藤提取物灌胃对高尿酸血症小鼠血清尿酸水平影响及对痛风大鼠足跖肿胀的防治作用[J].山东医药,2017,57(27):37-39.
董鹏,宋慧.痛风发病机制研究进展[J].基础医学与临床,2015,35(12):1695-1699.
梁晖,张意侗,解纪惠,等.急性痛风性关节炎患者血清IL-1β,IL-6, IL-8与疼痛的相关性[J].河北医学,2019,25(1):22-25.
C DHANASEKAR, M RASOOL. Morin, a dietary bioflavonol suppresses monosodium urate crystal-induced inflammation in an animal model of acute gouty arthritis with reference to NLRP3 inflammasome, hypo-xanthine phospho-ribosyl transferase, and inflammatory mediators[J].Eur J Pharmacol, 2016, 786:116-127.
Q B ZHANG, Y F QING, C C YIN, et al. Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome[J].Arthritis Res Ther, 2018, 20(1):45-55.
0
浏览量
12
下载量
4
CSCD
关联资源
相关文章
相关作者
相关机构